BIO vs CBNK · rev $651.0M vs P/E 9.9, rev $137.9M
BIO (BIO) versus Capital Bancorp (CBNK) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Capital Bancorp (CBNK) is a banks - regional company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported CBNK revenue for 2026-06-30 was $137.9M. Net income was $26.3M. CBNK currently screens at market cap $536.9M and trailing P/E 9.9.
BIO currently screens at market cap $0. CBNK currently screens at market cap $536.9M and trailing P/E 9.9.
Not investment advice. Open the BIO and CBNK stock pages for the full models.
Not investment advice.